Cheapest Mounjaro Diarrhoea UK Price From £124.99

Our Pricing

Understanding and Managing Diarrhoea on Mounjaro

Published on: June 03, 2026

Experiencing diarrhoea on Mounjaro UK treatment is one of the most commonly reported gastrointestinal side effects, affecting approximately 18-30% of patients in clinical trials [1]. As a UK-registered pharmacy with thousands of weight loss treatment consultations completed, our clinical team at Cured Pharmacy frequently supports patients through this manageable side effect. Understanding why it occurs and how to minimise discomfort can help you stay on track with your weight loss journey.

Why Does Mounjaro Cause Diarrhoea?

Mounjaro (tirzepatide) works by activating both GIP and GLP-1 receptors throughout your digestive system [1]. These receptors naturally slow gastric emptying — the rate at which food moves from your stomach into your intestines — which helps you feel fuller for longer and reduces appetite. However, this mechanism can temporarily disrupt your normal digestive rhythm, leading to loose stools or diarrhoea, particularly during the first few weeks of treatment or after dose increases.

The SURPASS-1 clinical trial documented gastrointestinal side effects in detail: diarrhoea occurred in 18% of patients on the 5mg dose, 21% on 10mg, and 30% on the 15mg maintenance dose [1]. Importantly, most cases were classified as mild to moderate in severity, and symptoms typically improved within 4-8 weeks as the body adapted to the medication. Only 4.3% of participants discontinued treatment due to gastrointestinal issues across all dose groups [2].

Unlike some weight loss medications that directly affect fat absorption (such as orlistat, which can cause urgent, oily stools), Mounjaro's mechanism works through hormone pathways. This means the diarrhoea you experience is related to altered gut motility rather than malabsorption, and it responds well to dietary adjustments and symptom management strategies recommended by UK prescribers.

How Long Does Diarrhoea on Mounjaro Last?

For most patients, diarrhoea is most pronounced during the first 2-4 weeks after starting Mounjaro or increasing to a higher dose [2]. Clinical data shows that gastrointestinal side effects peak within the first month and gradually diminish as your digestive system adjusts to the medication's effects on gut hormone receptors.

The gradual dose escalation schedule recommended by the MHRA — starting at 2.5mg weekly for four weeks, then increasing to 5mg — is specifically designed to minimise these side effects [3]. If you experience persistent diarrhoea beyond 8 weeks, or if symptoms are severe enough to cause dehydration, contact your prescribing clinician immediately. They may recommend staying at your current dose longer before escalating, or adjusting your treatment plan.

It's worth noting that each dose increase may trigger a brief recurrence of digestive symptoms lasting 1-2 weeks, though these episodes are typically milder than your initial experience. Keeping a symptom diary can help you and your UK prescriber identify patterns and optimise your dosing schedule for maximum comfort whilst maintaining therapeutic benefit.

Proven Strategies to Manage Diarrhoea on Mounjaro UK

Dietary Adjustments That Help

The most effective first-line approach is modifying your diet to support slower digestion. Focus on easily digestible, low-fat foods during the first few weeks: plain rice, bananas, toast, boiled potatoes, and lean proteins like chicken or white fish. Avoid high-fat meals, spicy foods, caffeine, and alcohol, all of which can exacerbate diarrhoea when your digestive system is already adjusting to Mounjaro.

Increasing soluble fibre intake can help bulk stools and regulate bowel movements. Oats, psyllium husk, and cooked vegetables are excellent choices. However, avoid sudden increases in insoluble fibre (bran, raw vegetables) as this may worsen symptoms initially. Small, frequent meals — eating every 3-4 hours rather than three large meals — can also reduce the burden on your digestive system.

Hydration and Electrolyte Balance

Diarrhoea increases fluid and electrolyte loss, which can lead to dehydration if not properly managed. Aim for at least 2-3 litres of water daily, increasing this if you're experiencing frequent loose stools. Clear broths, herbal teas, and oral rehydration solutions (available from any UK pharmacy without prescription) can help maintain electrolyte balance.

Watch for signs of dehydration: dark urine, dizziness, dry mouth, or reduced urination. If you experience these symptoms alongside persistent diarrhoea, contact your GP or prescribing clinician promptly. Severe dehydration may require temporary discontinuation of Mounjaro until symptoms resolve, though this is uncommon when proper hydration measures are followed.

Avoid relying solely on caffeinated drinks or fruit juices for hydration, as caffeine acts as a diuretic and high sugar content can worsen diarrhoea through osmotic effects. Plain water, diluted squash, or electrolyte drinks formulated for rehydration are your best options during this adjustment period.

When to Contact Your UK Prescriber About Diarrhoea on Mounjaro

Red Flag Symptoms Requiring Medical Review

Whilst mild to moderate diarrhoea is expected and manageable, certain symptoms warrant immediate medical attention. Contact your prescriber if you experience: diarrhoea lasting more than 7 consecutive days without improvement, blood or mucus in stools, severe abdominal cramping, fever above 38°C, or signs of dehydration despite adequate fluid intake.

Persistent diarrhoea can occasionally indicate conditions unrelated to Mounjaro that require investigation, such as gastroenteritis or inflammatory bowel conditions. Your UK prescriber may recommend temporarily pausing treatment, adjusting your dose, or conducting further assessment to rule out other causes. Never stop Mounjaro abruptly without clinical guidance, as your prescriber may suggest a gradual reduction if discontinuation is necessary.

Comparing Digestive Side Effects Across Weight Loss Treatments

How Mounjaro Compares to Wegovy and Saxenda

All GLP-1 receptor agonists licensed in the UK — including Wegovy (semaglutide) and Saxenda (liraglutide) — can cause gastrointestinal side effects due to their shared mechanism of slowing gastric emptying [4]. However, the incidence and severity vary between medications. In head-to-head trials, tirzepatide (Mounjaro) showed slightly higher rates of nausea and diarrhoea compared to semaglutide, though this correlated with greater average weight loss: 22.5% body weight reduction with tirzepatide versus 14.9% with semaglutide at comparable timepoints [1][4].

Orlistat-based treatments like Xenical work through an entirely different mechanism — blocking fat absorption in the intestines — which causes different digestive effects: oily stools, urgency, and anal leakage, particularly after high-fat meals. Many patients find the gastrointestinal profile of GLP-1 treatments like Mounjaro more tolerable and predictable, as symptoms typically improve over time rather than persisting throughout treatment.

Your choice between weight loss medications should be guided by a comprehensive consultation with a UK prescriber, who will consider your medical history, weight loss goals, tolerance for side effects, and lifestyle factors. At Cured Pharmacy, our clinical team completes a thorough assessment before recommending the most suitable treatment, with transparent pricing from £135.00 for Mounjaro provided upfront.

Scientific References

1. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14443 [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience severe or persistent diarrhoea, dehydration, or other concerning symptoms whilst taking Mounjaro, contact your prescriber or GP immediately.